Research & Development



  “是吧?”陸昔年得意的抬抬下巴,說他胖他還喘上了,“所以說,為了不搶別人的飯碗,我還是老老實實的當個cv好了。”   陸昔年︰下雨了,我們在哪兒等你?草莓在线观看   媽媽︰上星期不知道是誰把人家夸得天上有地下無, 夸完之後還一個勁的嘆氣。偷拍久久国产视频   “Lin神不露臉的第n天,想他想他!”   曉曉︰字面上的意思啊, 哈哈哈, 我想了好久才想到的稱呼, 是不是很貼切?97mm草莓视频   陳海也有同感,回想了一下︰“好像是秦樓的台詞。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo